MarginsXMarginsX
Home › Markets › Health Care › INFU

InfuSystems Holdings Inc. (INFU)

INFU trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$14.79
+0.48% on the day
Market cap
$296.3M
Micro cap
Revenue · 2025
$143.4M
+6.4% on 2024
Net income · 2025
$6.6M
4.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1337013/000162828026012804/0001628280-26-012804-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerINFU on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001337013
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$143.4M
Net income$6.6M
Operating income$11.9M
Net margin4.6%
Operating margin8.3%
Revenue growth+6.4%
Cash$3.2M
Total assets$100.6M
P/E (computed)44.7×
P/S (computed)2.1×

Warning signs

Cash runway
Cash-flow positive
$9.1M cash at September 30, 2026
Share count, 1 year
-1.5%
2025-10-31 to 2026-11-08 · -5.4% over 3 years
Going-concern doubt
No
10-Q filed November 9, 2026
Insider net buying, 12 months
$150K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-09
Cash and burn$9.1M cash; operating cash flow $6.3M a quarter.Report 2026-09-30
Shares outstanding20,033,488 (2026-11-08); 20,336,183 a year earlier; 21,183,526 three years earlier.Cover page 2026-11-08
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, Detroit, Michigan, United States; changed auditors 1 time in 24 months8-K 4.01 2026-03-19
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $150K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$37.6M$3.2M$10.3M$9.1M$19.7M$144.4M10-Q 2026-11-09
Q2 2026
2026-06-30
$36.9M$3.2M$6.8M$964K$20.4M$143.3M10-Q 2026-08-04
Q1 2026
2026-03-31
$33.7M$1.0M$970K$2.1M$19.6M$142.4M10-Q 2026-05-08
Q4 2025
2025-12-31
$36.2M$2.0M$7.1M$3.2M$19.6M$143.4M10-K 2026-02-27
Q3 2025
2025-09-30
$36.5M$2.3M$8.5M$955K$20.9M$141.1M10-Q 2026-11-09
Q2 2025
2025-06-30
$36.0M$2.6M$7.0M$720K$26.3M$139.9M10-Q 2026-08-04
Q1 2025
2025-03-31
$34.7M-$267K$1.8M$1.5M$28.7M$137.6M10-Q 2026-05-08
Q4 2024
2024-12-31
$33.8M$933K$7.9M$527K$23.9M$134.9M10-K 2026-02-27

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B12010-10-19
Latest annual report10-K2026-02-27
Latest quarterly / interim10-Q2026-11-09
Latest current report8-K2026-11-09
Latest proxyDEF 14A2026-04-10

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+7.5%
1 month+9.1%
3 months+17.9%
Year to date+64.1%
1 year+44.9%
From 52-week high-3.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
TMCITreace Medical Concepts Inc.$4.42-16.13%$289.8M
OFIXOrthofix Medical Inc. Common Stock (DE)$6.80-5.16%$277.2M
NPCENeuropace Inc.$7.97+5.42%$274.6M
SSIISS Innovations International Inc.$1.35-18.67%$270.7M
PROFProfound Medical Corp.$7.34-1.08%$268.8M
CLPTClearPoint Neuro Inc.$8.30-2.12%$266.1M
OSUROraSure Technologies Inc.$3.60-0.55%$248.6M
EMBCEmbecta Corp.$6.25-3.25%$354.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier